What chest X‑ray findings are associated with reactive airway disease and what is the appropriate management?

Chest X-Ray Findings in Reactive Airway Disease

Chest X-rays in reactive airway disease are primarily obtained to exclude life-threatening complications (pneumothorax, consolidation, pulmonary edema) rather than to diagnose the condition itself, as most films show either hyperinflation or are entirely normal 1.

Typical Radiographic Findings

The chest X-ray findings associated with reactive airway disease include:

• Hyperinflation/overinflation (seen in approximately 32% of acute asthma cases) 2
• Normal chest radiograph (25-68% of cases) 3
• Flattened diaphragms and increased anteroposterior diameter (signs of air trapping)
• Peribronchial thickening (chronic changes)

Critical Pathologic Findings to Exclude

The primary purpose of obtaining a chest X-ray is to identify complications that would alter management 1:

• Pneumothorax
• Pneumonia/consolidation
• Pulmonary edema
• Atelectasis (found in approximately 5% of cases) 2

When to Order Chest Radiography

Obtain chest X-ray in hospitalized patients with acute severe asthma to exclude complications 1. The guidelines specifically recommend chest radiography as part of "Further Investigations in Hospital" for patients requiring admission.

For first-time wheezing episodes in children, chest X-ray is recommended because clinical variables alone cannot reliably predict pathologic findings—approximately 6.2% will have significant pathology that changes management 3.

Management Algorithm

Immediate Treatment (Before or Concurrent with Imaging)

Do not delay treatment waiting for radiography 1:

1. High-dose inhaled β-agonists: Salbutamol 5 mg or terbutaline 10 mg nebulized with oxygen, or 20-40 puffs via MDI with spacer

2. High-dose systemic corticosteroids: Prednisolone 30-60 mg PO or hydrocortisone 200 mg IV immediately

3. If life-threatening features present:

   • Add ipratropium 0.5 mg nebulized
   • Consider IV aminophylline 250 mg over 20 minutes (avoid if already on oral theophyllines) or IV salbutamol/terbutaline 250 µg over 10 minutes

Monitoring Response

• Measure peak expiratory flow 15-30 minutes after initial treatment
• Continue oxygen therapy
• If improving: nebulized β-agonist every 4 hours
• If not improving: increase frequency to every 15 minutes

Hospital Admission Criteria

Admit if peak expiratory flow remains <33% of predicted 15-30 minutes after nebulization, or if life-threatening features persist 1.

Common Pitfalls

Critical caveat: Normal chest X-ray does NOT exclude significant inflammatory or infectious lung disease. The negative predictive value is only 65-66% for inflammation and 87.5% for infection 4. Clinical assessment and response to bronchodilators remain paramount.

Avoid these errors 1:

• Do not give antibiotics unless bacterial infection is confirmed on imaging
• Never use sedation in acute bronchospasm
• Avoid chest physiotherapy—it provides no benefit

Life-Threatening Indicators Requiring ICU

Regardless of X-ray findings, transfer to intensive care if 1:

• PaCO₂ normal (5-6 kPa) or elevated in breathless patient
• PaO₂ <8 kPa despite 60% oxygen
• Exhaustion, confusion, drowsiness, or decreased respiratory effort

The chest X-ray finding of hyperinflation correlates with lower PaO₂ on admission but does not independently predict need for escalation of care 2.